tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SE:CAMX Stock Latest News

Camurus Strengthens Executive Team With New Corporate Development Chief
Company AnnouncementsCamurus Strengthens Executive Team With New Corporate Development Chief
3d ago
Camurus AB Earnings Call: Growth, FX and U.S. Push
PremiumCompany Announcements
Camurus AB Earnings Call: Growth, FX and U.S. Push
6d ago
Camurus Posts Strong 2025 Earnings, Expands Long-Acting Endocrine Portfolio
PremiumCompany Announcements
Camurus Posts Strong 2025 Earnings, Expands Long-Acting Endocrine Portfolio
8d ago
CAMRF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CAMRF Upcoming Earnings Report: What to Expect?
10d ago
Camurus announces FDA acceptance of NDA resubmission for Oclaiz
PremiumThe Fly
Camurus announces FDA acceptance of NDA resubmission for Oclaiz
1M ago
Camurus’ acromegaly drug Oclaiz gains FDA review date after resubmitted US filing
PremiumCompany AnnouncementsCamurus’ acromegaly drug Oclaiz gains FDA review date after resubmitted US filing
1M ago
Camurus Increases Share Capital After Employee Stock Option Exercise
Premium
Company Announcements
Camurus Increases Share Capital After Employee Stock Option Exercise
2M ago
Camurus Increases Shares and Votes Following Employee Stock Option Exercise
Premium
Company Announcements
Camurus Increases Shares and Votes Following Employee Stock Option Exercise
3M ago
Camurus Announces Nomination Committee for AGM 2026
PremiumCompany Announcements
Camurus Announces Nomination Committee for AGM 2026
3M ago
Camurus AB Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Camurus AB Earnings Call: Growth Amid Challenges
3M ago
Camurus Reports Positive Phase 1b Results for Monthly Semaglutide Depot
PremiumCompany Announcements
Camurus Reports Positive Phase 1b Results for Monthly Semaglutide Depot
3M ago
Camurus AB Reports Strong Q3 Growth Amid Revised Outlook
PremiumCompany Announcements
Camurus AB Reports Strong Q3 Growth Amid Revised Outlook
4M ago
Camurus AB Reports Strong Q3 2025 Financial Performance and Strategic Milestones
PremiumCompany AnnouncementsCamurus AB Reports Strong Q3 2025 Financial Performance and Strategic Milestones
4M ago
Camurus Increases Shares and Votes Following Employee Stock Option Exercise
Premium
Company Announcements
Camurus Increases Shares and Votes Following Employee Stock Option Exercise
5M ago
Camurus AB Reports Strong Q2 2025 Financial Results
Premium
Company Announcements
Camurus AB Reports Strong Q2 2025 Financial Results
7M ago
Camurus Reports Robust Growth in Q2 2025
PremiumCompany Announcements
Camurus Reports Robust Growth in Q2 2025
7M ago
Camurus AB (CAMRF) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Camurus AB (CAMRF) Q2 Earnings Cheat Sheet
7M ago
Camurus upgraded to Buy from Hold at DNB Carnegie
PremiumThe Fly
Camurus upgraded to Buy from Hold at DNB Carnegie
8M ago
Camurus’ Oczyesa Gains EU Approval for Acromegaly Treatment
PremiumCompany Announcements
Camurus’ Oczyesa Gains EU Approval for Acromegaly Treatment
8M ago
Camurus Expands Share Count to Support Employee Incentive Program
PremiumCompany AnnouncementsCamurus Expands Share Count to Support Employee Incentive Program
8M ago
Camurus’ POSITANO Study Shows Promising Results for PLD Treatment
Premium
Company Announcements
Camurus’ POSITANO Study Shows Promising Results for PLD Treatment
8M ago
Eli Lilly Strikes $870 Million Deal to Develop Long-Acting Obesity Treatments
Premium
Market News
Eli Lilly Strikes $870 Million Deal to Develop Long-Acting Obesity Treatments
9M ago
LLY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >